News Daily News Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data Michael O'Riordan November 26, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages Michael O'Riordan November 12, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Daily News Diabetes Drug Canagliflozin Gets MACE Reduction Indication Todd Neale November 01, 2018
Presentation ESC 2018 ASCEND A Randomized Trial of Omega-3 Fatty Acids (fish oil) vs Placebo Presenter: Jane Armitage August 27, 2018
Presentation ESC 2018 ASCEND Randomized placebo-controlled trial of aspirin Presenter: Jane Armitage August 27, 2018
News Conference News ESC 2018 ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients Todd Neale August 26, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018
News Conference News CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin Michael O'Riordan March 16, 2018
News Daily News ‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large Michael O'Riordan January 30, 2018
News Daily News Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years Michael O'Riordan January 18, 2018
News Daily News Gestational Diabetes Increases Risk of Ischemic Heart Disease Michael O'Riordan January 16, 2018
News Daily News Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery Yael L. Maxwell January 09, 2018